Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND

Compañía Compartir, %
Contineum Therapeutics, Inc. Contineum Therapeutics, Inc. 2.77
Context Therapeutics Inc. Context Therapeutics Inc. 1.65
Alto Neuroscience, Inc. Alto Neuroscience, Inc. 1.58
IN8bio, Inc. IN8bio, Inc. 1.53
EyePoint Pharmaceuticals, Inc. EyePoint Pharmaceuticals, Inc. 1.5
HilleVax, Inc. HilleVax, Inc. 1.38
Oruka Therapeutics, Inc. Oruka Therapeutics, Inc. 0.95
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc. 0.79
enGene Holdings Inc. enGene Holdings Inc. 0.7
Merus N.V. Merus N.V. 0.66
ARS Pharmaceuticals, Inc. ARS Pharmaceuticals, Inc. 0.66
Satellos Bioscience Inc. 0.63
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc. 0.57
MBX Biosciences, Inc. Common Stock 0.52
Akebia Therapeutics, Inc. Akebia Therapeutics, Inc. 0.34
ABIVAX Société Anonyme 0.29

Categoría Cantidad
Healthcare 11